SCHEMBL4002611

SCHEMBL4002611

CSc1nccc(Nc2cc(-c3ccccc3)c3ncn(CCc4ccccc4)c3c2)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ HTT P42858 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.35
▸ LMNA P02545 2/20 0.35
▸ TP53 P04637 2/20 0.35
▸ CNOT7 Q9UIV1 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ PTBP1 P26599 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ CREBBP Q92793 1/20 0.35
▸ KDR P35968 3/20 0.35
▸ MAPT P10636 2/20 0.35
▸ PDE4A P27815 1/20 0.35
▸ PDE4B Q07343 1/20 0.35
▸ PDE4C Q08493 1/20 0.35
▸ PDE4D Q08499 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5914406 0.72 MEN1 (0.41) KMT2AMEN1NPC1RAB9ALMNA
SCHEMBL5264043 0.70 DHODH (0.47) KMT2AMEN1NPC1RAB9AALDH1A1
SCHEMBL3926834 0.69 LMNA (0.39) KMT2AMEN1HTTALDH1A1LMNA
SCHEMBL2228112 0.68 AURKA (0.59) KMT2AMEN1NPC1RAB9ALMNA
SCHEMBL3922575 0.68 LMNA (0.50) KMT2AMEN1ALDH1A1LMNASMN1; SMN2
SCHEMBL5914227 0.64 MEN1 (0.43) KMT2AMEN1NPC1RAB9AALDH1A1
SCHEMBL24444297 0.63 EGLN3 (0.46) KMT2AMEN1ALDH1A1LMNASMN1; SMN2
SCHEMBL3923592 0.63 DPP4 (0.37) ALDH1A1SMN1; SMN2NPSR1KDRMAPT
SCHEMBL5314182 0.62 MEN1 (0.42) KMT2AMEN1NPC1RAB9AALDH1A1
SCHEMBL23579969 0.62 CYP11B1 (0.42) LMNAKDRADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2041118-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS AND METHODS OF USE Amgen, Inc (US) 2009-04-01 — — EP disclosed
WO-2007114827-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2007-10-11 — — WO disclosed
Send feedback